<?xml version='1.0' encoding='iso-8859-1'?>
<newsitem date="1997-07-08" id="root" itemid="713876" xml:lang="en">
<title>USA: Dura Pharm files for $200 mln debt offer.</title>
<headline>Dura Pharm files for $200 mln debt offer.</headline>
<dateline>SAN DIEGO 1997-07-08</dateline>
<text>
<p>Dura Pharmaceuticals Inc said Tuesday it had filed with the Securities and Exchange Commission for a public offering of up to $200 million in convertible subordinated notes due 2002.</p>
<p>The offering will be made through Merrill Lynch &amp; Co and Goldman, Sachs &amp; Co as co-managers. Underwriters have a 30-day over-allotment option on an additional $30 million of the notes.</p>
<p>Dura makes prescription drugs for the treatment of allergies, asthma and related respiratory conditions.</p>
</text>
<copyright>(c) Reuters Limited 1997</copyright>
<metadata>
<dc element="dc.date.created" value="1997-07-08" />
<dc element="dc.publisher" value="Reuters Holdings Plc" />
<dc element="dc.date.published" value="1997-07-08" />
<dc element="dc.source" value="Reuters" />
<dc element="dc.creator.location" value="SAN DIEGO" />
<dc element="dc.creator.location.country.name" value="USA" />
<dc element="dc.source" value="Reuters" />
</metadata>
</newsitem>